PMID: 4884653Feb 15, 1969Paper

Azathioprine in rheumatoid arthritis

British Medical Journal
M MasonI D Strickland

Abstract

The ability of azathioprine to reduce the corticosteroid requirements of patients with severe rheumatoid arthritis was tested under double-blind conditions against placebo. After 12 months a significant mean dose reduction of 36% was achieved without undue side-effects. This form of therapy promises to be an advance in the management of severe rheumatoid arthritis.

References

Sep 18, 1965·Lancet·I Lorenzen, A Videbaek
Sep 1, 1966·The American Journal of Medicine·C C CorleyW E Larsen
Apr 1, 1968·Arthritis and Rheumatism·W M FosdickD F Hill

❮ Previous
Next ❯

Citations

Mar 22, 1976·European Journal of Clinical Pharmacology·K M GOEBELU Börngen
Jan 1, 1988·Springer Seminars in Immunopathology·P A MiescherR H Zubler
Jan 15, 2008·European Journal of Clinical Pharmacology·Shirley Kow Yin KhamAllen Eng Juh Yeoh
May 1, 2006·Clinics in Colon and Rectal Surgery·Sean C Glasgow, David W Dietz
Aug 3, 1972·The New England Journal of Medicine·M D Skinner, R S Schwartz
Oct 27, 1983·The New England Journal of Medicine·L IannuzziI Kushner
May 12, 1994·The New England Journal of Medicine·J M Cash, J H Klippel
Jul 29, 2005·Journal of Gastroenterology and Hepatology·Richard B Gearry, Murray L Barclay
Jan 1, 1976·Australian and New Zealand Journal of Medicine·K D Muirden, D R Barraclough
Aug 1, 1977·Australian and New Zealand Journal of Medicine·G R SymingtonR P Lambert
Mar 1, 1970·Annals of the Rheumatic Diseases·A J SwannellJ Q Matthias
May 1, 1970·Annals of the Rheumatic Diseases·E J DenmanR B Heath
Jan 1, 1971·Annals of the Rheumatic Diseases·J M GumpelF W Webb
Oct 1, 1980·Annals of the Rheumatic Diseases·P LewisS Roberts
Aug 1, 1981·Annals of the Rheumatic Diseases·J WoodlandH L Currey
Dec 1, 1981·Annals of the Rheumatic Diseases·M De Silva, B L Hazleman
Feb 1, 1986·Annals of the Rheumatic Diseases·M De Silva, B L Hazleman
Aug 1, 1975·The British Journal of Ophthalmology·W J Dinning, E S Perkins
Feb 20, 1971·British Medical Journal·A S DixonE M Collins
Apr 5, 1975·British Medical Journal·M AylwardD B Davies
Apr 5, 1980·British Medical Journal·V Wright, R Amos
Dec 5, 1970·British Medical Journal·G P ArdenB M Ansell
Nov 1, 1971·Thorax·N G HodgesJ B Howell
Apr 1, 1974·Australian and New Zealand Journal of Medicine·K D MuirdenM Phillips
Jan 1, 1982·International Rehabilitation Medicine·W M Zinn
Jan 1, 1981·International Journal of Radiation Oncology, Biology, Physics·S StroberH S Kaplan
Aug 8, 2009·British Journal of Clinical Pharmacology·Shirley Kow Yin KhamAllen Eng Juh Yeoh
May 1, 1983·Seminars in Arthritis and Rheumatism·G D GroffT H Taylor
Dec 1, 1990·Baillière's Clinical Rheumatology·R A LuqmaniP A Bacon
Dec 30, 1983·The American Journal of Medicine·J L Decker
Jul 1, 1970·Acta paediatrica Scandinavica·M W HilgartnerC H Smith
Sep 1, 1970·Arthritis and Rheumatism
Oct 18, 2000·The Cochrane Database of Systematic Reviews·M E Suarez-AlmazorE Belseck
Mar 1, 1977·Arthritis and Rheumatism·I L DwoshM A Ogryzlo
Sep 1, 1989·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·M E Weinblatt, A L Maier
Jan 1, 1973·Arthritis and Rheumatism·A D Steinberg
May 1, 1976·Arthritis and Rheumatism·A S TownesL E Shulman
Jan 1, 1979·Journal of Immunopharmacology·R VinegarP R Johnston
Mar 1, 1986·Journal of the Royal Society of Medicine·C CooperM I Cawley
Jun 29, 2017·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Ahmed ShahSaeid Amini-Nik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.